Biosimilars Market

  • Published on 2025-11-11
  • Report Code: 361
  • 179 pages
Biosimilars Market

U.S Biosimilars Market By Product type (Recombinant Non-Glycosylated Proteins, Recombinant Glycosylated Proteins); By Application (Chronic & Autoimmune Disorders, Blood Disorders, Oncology, and Growth Hormone); By Manufacturer (Contract Research and Manufacturing, In-house Manufacturing); and Region -Analysis of Market Size, Share & Trends for 2016 - 2019 and Forecasts to 2029

Table Of Content

Contents       

  1. Executive Summary
  2. US Biosimilars
    1. Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  6. Correlation & Regression Analysis
    1. Correlation Matrix
    2. Regression Matrix
  7. Recent Development, Policies & Regulatory Landscape
  8. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  9. US Biosimilars Industry Analysis
    1. Porters Five Forces
      1. Threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  10. US Biosimilars Market
    1. Market Size & forecast, 2019A-2030F
      1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. By Volume (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  11. US Biosimilars Market: Market Segmentation
    1. By Regions
      1. US:
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    2. By Product type: Market Share (2020-2030F)
      1. Recombinant Non-Glycosylated Proteins, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. Recombinant Glycosylated Proteins, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  12. By Application: Market Share (2020-2030F)
    1. Chronic & Autoimmune Disorders, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    2. Blood Disorders, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    3. Oncology, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    4. Growth Hormone, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  13. Company Profile
    1. Pfizer
      1. Company Overview
      2. Company Total Revenue (Financials)
      3. Market Potential
      4. Global Presence
      5. Key Performance Indicators
      6. SWOT Analysis
      7. Product Launch
    2. Apotex/Apobiologix
    3. Coherus Biosciences
    4. Merck & Co.
    5. Biogen
    6. Amgen
    7. Teva Pharmaceutical Industries
    8. STADA Arzneimittel
    9. Other prominent players

Consultant Recommendation

**The above-given segmentation and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable

To request a free sample copy of this report, please complete the form below.

Select License Type

$ 4950

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

Read all reports

Our Clients

We have been working with some Fortune 500+ clients